Clinical Trials for Spondylosis

Several clinical trials for spondylosis are recruiting patients.  Spondylosis is the medical term for degenerative osteoarthritis that develops in the spine’s joints.  Many people age 60 and older may have cervical (neck) or lumbar (low back) spondylosis.  The condition is often detectable on an x-ray.  Symptoms typically include mild to severe pain that may radiate (travel) into an extremity (your arm or leg).

Clinical trials are research studies that help improve detection and treatment of spinal osteoarthritis.  As the whole population of the United States steadily grows older, the need for patients with spondylosis in clinical trials increases.  Through human studies, doctors and research specialists gain knowledge about spondylosis, in turn making application by developing technologies (eg, medications, biologics, and devices) that improve quality of life for mature adults and the elderly.  

Why Volunteer to Participate in a Spondylosis Clinical Trial?

Participation in a clinical trial for spondylosis gives you the opportunity to become more informed and active in your medical care.  You may be able to receive a new treatment that is not readily available to the public, and the medical professionals who conduct the research study are focused on spondylosis. 

Who Is Responsible for My Care During a Clinical Trial?

Your regular doctor (eg, primary care physician) continues to be essential to your medical care. 

The Principal Investigator of the clinical trial is often a board-certified and/or fellowship-trained doctor who specializes in treating spondylosis, such as a rheumatologist, neurosurgeon, or orthopaedic spine surgeon.  Sometimes, there are more than one lead investigator supported by clinical trial coordinators and nursing staff.

Is a Clinical Trial for Spondylosis Safe?

It is important to understand that any medical treatment or therapy has risks.  While a clinical study may focus on spondylosis, patient safety is paramount.  In fact, a clinical trial is not allowed to recruit participants until the study’s plan (called a protocol) receives approval by an Institutional Review Board (IRB).  Of course, other necessary approvals are needed too.  IRBs follow regulations set forth by the United States Food and Drug Administration (FDA).


Informed Consent is another safeguard.  The Informed Consent written document details the risks associated with spondylosis study participation and possible benefits.  Participants are free to withdraw from a clinical trial at any time.